---
$id: https://graph.org.ai/products/commodity/51361908
$type: Product
source: UNSPSC
code: "51361908"
title: "Hexobarbital or hexobarbitone"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Hexobarbital or hexobarbitone

**UNSPSC Code**: 51361908
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C12H16N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AL8Z8K3P6S, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-(1-cyclohexen-1-yl)-1,5-dimethyl-, monosodium salt but generally known as hexobarbital, which bears US NIH Compound Identifier 3608. European Medicines Agency schedules Hexobarbital in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08038MIG. The term HEXOBARBITAL is an International Non-Proprietary Name. World Health Organization schedules hexobarbital in its Anatomical Therapeutic Chemical (ATC) Classification. HEXOBARBITAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Hexobarbital or hexobarbitone bears US NLM identifiers UMLS ID C0019469 and NCI Concept Code C77630. SMILES: CC1(C(=O)NC(=O)N(C1=O)C)C2=CCCCC2.

